Italia markets closed

ResMed Inc. (0KW4.L)

LSE - LSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
222,81+7,71 (+3,59%)
Alla chiusura: 04:23PM BST
Schermo intero
Chiusura precedente215,10
Aperto218,75
Denaro0,00 x 0
Lettera0,00 x 0
Min-Max giorno218,75 - 222,81
Intervallo di 52 settimane218,75 - 222,81
Volume561
Media VolumeN/D
Capitalizzazione313,392M
Beta (5 anni mensile)0,50
Rapporto PE (ttm)0,42
EPS (ttm)5,30
Prossima data utili26 ott 2022 - 31 ott 2022
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    ResMed Announces Participation in the Bank of America Global Healthcare Conference

    SAN DIEGO, Sept. 07, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a fireside chat at the Bank of America Global Healthcare Conference on Wednesday, September 14, 2022, beginning at approximately 9:05 a.m. (British Summer Time) at the Bank of America Financial Centre in London. More information about this event, including a live webcast, may be accessed by visiting http://investor.resmed.com. The webcast replay wi

  • GlobeNewswire

    ResMed Announces Participation in the 20th Annual Morgan Stanley Global Healthcare Conference

    SAN DIEGO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will participate in a fireside chat at the 20th Annual Morgan Stanley Global Healthcare Conference on Monday, September 12, 2022, beginning at approximately 8:45 a.m. (Eastern Daylight Time) at the Sheraton New York in New York City. More information about this event, including a live webcast, may be accessed by visiting http://investor.resmed.com. The we

  • GlobeNewswire

    Over 480 Million People Estimated to Have COPD, World’s Third Deadliest Disease, ResMed Study Reports

    New prevalence figure 22–126% higher than previous estimatesPrevalence expected to reach 592 million by 2050Researchers urge global action on smoking cessation and air pollution reduction BARCELONA, Spain, Sept. 04, 2022 (GLOBE NEWSWIRE) -- Over 480 million people worldwide likely suffer from chronic obstructive pulmonary disease, or COPD, according to a late-breaking abstract led by ResMed (NYSE: RMD, ASX: RMD) presented at the European Respiratory Society Congress today.1 This figure is 22–126